Melanie Oates

612 total citations
19 papers, 240 citations indexed

About

Melanie Oates is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Melanie Oates has authored 19 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Melanie Oates's work include Chronic Lymphocytic Leukemia Research (13 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Melanie Oates is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Melanie Oates collaborates with scholars based in United Kingdom, United States and Netherlands. Melanie Oates's co-authors include Andrew R. Pettitt, Gillian G. Johnson, Ke Lin, Robert Brown, Fiona Douglas, W. Nicol Keith, R.P. Symonds, Jianguo Zhuang, David Oscier and Daniel Catovsky and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Melanie Oates

17 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melanie Oates United Kingdom 9 130 84 69 46 43 19 240
Gillian G. Johnson United Kingdom 8 120 0.9× 83 1.0× 89 1.3× 42 0.9× 57 1.3× 9 221
Petr Kosztyu Czechia 10 94 0.7× 124 1.5× 43 0.6× 46 1.0× 32 0.7× 23 286
Joshua M. Eichhorn United States 6 177 1.4× 94 1.1× 29 0.4× 19 0.4× 26 0.6× 14 280
Nandini Sakurikar United States 8 236 1.8× 136 1.6× 33 0.5× 20 0.4× 29 0.7× 10 337
Ana E. Rodríguez‐Vicente Spain 10 88 0.7× 57 0.7× 134 1.9× 87 1.9× 79 1.8× 18 246
J A P Spijkers-Hagelstein Netherlands 7 150 1.2× 55 0.7× 28 0.4× 54 1.2× 26 0.6× 9 293
M. Georget France 5 78 0.6× 78 0.9× 42 0.6× 53 1.2× 40 0.9× 6 287
Marlena Walls United States 8 202 1.6× 84 1.0× 16 0.2× 29 0.6× 34 0.8× 11 312
Devin Worster United States 4 255 2.0× 153 1.8× 32 0.5× 34 0.7× 35 0.8× 6 410
Bettina Wingelhofer Austria 9 205 1.6× 123 1.5× 44 0.6× 93 2.0× 42 1.0× 12 377

Countries citing papers authored by Melanie Oates

Since Specialization
Citations

This map shows the geographic impact of Melanie Oates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Oates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Oates more than expected).

Fields of papers citing papers by Melanie Oates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Oates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Oates. The network helps show where Melanie Oates may publish in the future.

Co-authorship network of co-authors of Melanie Oates

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Oates. A scholar is included among the top collaborators of Melanie Oates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Oates. Melanie Oates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Boutzoukas, Angelique E, Melanie Oates, Ross Maltz, et al.. (2022). Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease. Pediatric Quality and Safety. 7(4). e570–e570. 3 indexed citations
3.
Boyle, Brendan, et al.. (2021). The Pediatric Inflammatory Bowel Disease Medical Home: A Proposed Model. Inflammatory Bowel Diseases. 28(9). 1420–1429. 5 indexed citations
4.
Eagle, Gina, John Herbert, Jianguo Zhuang, et al.. (2021). Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells. Scientific Reports. 11(1). 2932–2932. 7 indexed citations
5.
Lin, Ke, Melanie Oates, Umair Khan, et al.. (2020). Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia. Leukemia & lymphoma. 62(1). 45–57. 4 indexed citations
6.
Crandall, Wallace, et al.. (2019). A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 69(5). 544–550. 7 indexed citations
7.
Crandall, Wallace, et al.. (2019). Improving Post‐induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 70(1). 48–54. 8 indexed citations
8.
Beck, Daniel, Dena Howard, Peter Hillmen, et al.. (2018). An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects. BMC Research Notes. 11(1). 280–280. 4 indexed citations
9.
Chapman, Elinor, Melanie Oates, Barry R. Davies, et al.. (2017). Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia. Oncotarget. 8(61). 102948–102964. 8 indexed citations
10.
Robbe, Pauline, Kate Ridout, Jennifer Becq, et al.. (2016). Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot. Blood. 128(22). 2022–2022. 1 indexed citations
11.
Eagle, Gina, Jianguo Zhuang, Rosalind E. Jenkins, et al.. (2015). Total Proteome Analysis Identifies Migration Defects as a Major Pathogenetic Factor in Immunoglobulin Heavy Chain Variable Region (IGHV)-unmutated Chronic Lymphocytic Leukemia. Molecular & Cellular Proteomics. 14(4). 933–945. 27 indexed citations
12.
Zhuang, Jianguo, Naomi Laing, Melanie Oates, et al.. (2014). Selective IAP inhibition results in sensitization of unstimulated but not CD40‐stimulated chronic lymphocytic leukaemia cells to TRAIL‐induced apoptosis. Pharmacology Research & Perspectives. 2(6). e00081–e00081. 9 indexed citations
13.
Eagle, Gina, Rosalind E. Jenkins, Kathleen J. Till, et al.. (2014). Total Proteome Analysis Identifies Migration Defects As a Major Pathogenetic Factor in IGHV-Unmutated Chronic Lymphocytic Leukemia. Blood. 124(21). 718–718. 3 indexed citations
14.
15.
Lin, Ke, Yi Yang, Gillian G. Johnson, et al.. (2014). Loss of MIR15A and MIR16‐1 at 13q14 is associated with increased TP53 mRNA, de‐repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia. British Journal of Haematology. 167(3). 346–355. 21 indexed citations
16.
Johnson, Gillian G., Ke Lin, Trevor F. Cox, et al.. (2013). CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia. Blood. 122(26). 4253–4258. 26 indexed citations
17.
Lin, Ke, Janet Adamson, Gillian G. Johnson, et al.. (2012). Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration. Clinical Cancer Research. 18(15). 4191–4200. 26 indexed citations
18.
Lin, Ke, Brian Lane, Anthony Carter, et al.. (2012). The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under‐expression of TP53 and other genes on chromosome 17p. British Journal of Haematology. 160(1). 53–62. 8 indexed citations
19.
Douglas, Fiona, et al.. (1994). Topoisomerase I and II activity in human breast, cervix, lung and colon cancer. International Journal of Cancer. 59(5). 607–611. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian G. Johnson Breakdown of academic impact, for papers by Petr Kosztyu Breakdown of academic impact, for papers by Joshua M. Eichhorn Breakdown of academic impact, for papers by Nandini Sakurikar Breakdown of academic impact, for papers by Ana E. Rodríguez‐Vicente Breakdown of academic impact, for papers by J A P Spijkers-Hagelstein Breakdown of academic impact, for papers by M. Georget Breakdown of academic impact, for papers by Marlena Walls Breakdown of academic impact, for papers by Devin Worster Breakdown of academic impact, for papers by Bettina Wingelhofer
Rankless by CCL
2026